ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Garb’s Questions, Answers About Cancer Program

December 5, 1980

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999